IP Library Granted Patent US 10,472,341
Granted Patent B2
US 10,472,341 · App. 15/554,354 · Granted Nov 12, 2019

Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases

Inventors: Monika Ermann (Oxfordshire, GB); Guenther Lametschwandtner (Vienna, AT); Patricia Leonie Amouzegh (Oxfordshire, GB); Russell Stuart Craft (Groningen, NL); Thomas Hanke (Hamburg, DE); Timothy Robin James (Oxfordshire, GB); Severine Danielle Jones (Oxfordshire, GB); Hans Loibner (Vienna, AT); Pui Leng Loke (Oxfordshire, GB); Ina Sternberger (Hamburg, DE); Anton Stuetz (Altmuenster, AT); Roland Wehr (Goettingen, DE); Mark Whittaker (Oxfordshire, GB)
Assignees: APEIRON BIOLOGICS AG; EVOTEC SE
C07D285/36A61K31/554A61K45/06A61P35/00C07D417/06C07D417/10C07D417/12C07D417/14C07D513/04C12N5/0635C12N5/0636C12N5/0646C12N2501/2302C12N2501/999
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,472,341
App. No.
15/554,354
Granted
Nov 12, 2019
Kind
B2
Abstract

The present invention relates to bicyclic tetrahydrothiazepine of formula (I), wherein R 1 to R 3 , X 1 , X 2 and R 18 have the meaning as indicated in the description and claims. The invention further relates to pharmaceutical compositions comprising such compounds as well as their use as medicaments, especially in methods for the treatment or prevention of a neoplastic and/or infectious disease and in vitro methods.

Claims (250)

1. A pharmaceutical composition comprising at least one pharmaceutically acceptable carrier and at least one compound of formula (I)

or a pharmaceutically acceptable salt thereof, wherein

X 1 is S; S(O); or S(O) 2 ;

X 2 is N; or C(R 4 );

R 1 is H; or methyl;

R 2 is phenyl; 3 to 7 membered heterocyclyl; or 7 to 11 membered heterobicyclyl, wherein R 2 is optionally substituted with one or more R 5 , which are the same or different;

R 5 is halogen; CN; C(O)OR 6 ; OR 6 ; C(O)R 6 ; C(O)N(R 6 R 6a ); S(O) 2 N(R 6 R 6a ); S(O)N(R 6 R 6a ); S(O) 2 R 6 ; S(O)R 6 ; N(R 6 )S(O) 2 N(R 6a R 6b ); SR 6 ; N(R 6 R 6a ); OC(O)R 6 ; N(R 6 )C(O)R 6a ; N(R 6 )S(O) 2 R 6a ; N(R 6 )S(O)R 6a ; N(R 6 )C(O)OR 6a ; N(R 6 )C(O)N(R 6a R 6b ); OC(O)N(R 6 R 6a ); oxo (═O), where the ring is at least partially saturated; T 1 ; C 1-6 alkyl; C 2-6 alkenyl; or C 2-6 alkynyl, wherein C 1-6 alkyl; C 2-6 alkenyl; and C 2-6 alkynyl are optionally substituted with one or more halogen, which are the same or different;

R 6 , R 6a , and R 6b are independently selected from the group consisting of H; C 1-6 alkyl, C 2-6 alkenyl; and C 2-6 alkynyl, wherein C 1-6 alkyl; C 2-6 alkenyl; and C 2-6 alkynyl are optionally substituted with one or more halogen, which are the same or different;

T 1 is phenyl; C 3-7 cycloalkyl; or 3 to 7 membered heterocyclyl, wherein T 1 is optionally substituted with one or more R 7 , which are the same or different;

R 7 is halogen; CN; C(O)OR 8 ; OR 8 ; C(O)R 8 ; C(O)N(R 8 R 8a ); S(O) 2 N(R 8 R 8a ); S(O)N(R 8 R 8a ); S(O) 2 R 8 ; S(O)R 8 ; N(R 8 )S(O) 2 N(R 8a R 8b ); SR 8 ; N(R 8 R 8a ); OC(O)R 8 ; N(R 8 )C(O)R 8a ; N(R 8 )S(O) 2 R 8a ; N(R 8 )S(O)R 8a ; N(R 8 )C(O)OR 8a ; N(R 8 )C(O)N(R 8a R 8b ); OC(O)N(R 8 R 8a ); oxo (═O), where the ring is at least partially saturated; C 1-6 alkyl; C 2-6 alkenyl; or C 2-6 alkynyl, wherein C 1-6 alkyl; C 2-6 alkenyl; and C 2-6 alkynyl are optionally substituted with one or more halogen, which are the same or different;

R 8 , R 8a , and R 8b are independently selected from the group consisting of H; C 1-6 alkyl; C 2-6 alkenyl; and C 2-6 alkynyl, wherein C 1-6 alkyl; C 2-6 alkenyl; and C 2-6 alkynyl are optionally substituted with one or more halogen, which are the same or different;

R 3 is R 3a ; OR 3a ; NHR 3a ; or NHC(O)R 3a ;

R 3a is T 2 ; C 1-12 alkyl; C 2-12 alkenyl; or C 2-12 alkynyl, wherein C 1-12 alkyl; C 2-12 alkenyl; and C 2-12 alkynyl are optionally substituted with one or more R 9 , which are the same or different;

R 9 is halogen; CN; C(O)OR 10 ; OR 10 ; C(O)R 10 ; C(O)N(R 10 R 10a ); S(O) 2 N(R 10 R 10a ); S(O)N(R 10 R 10a ); S(O) 2 R 10 ; S(O)R 10 ; N(R 10 )S(O) 2 N(R 10a R 10b ); SR 10 ; N(R 10 R 10a ); OC(O)R 10 ; N(R 10 )C(O)R 10a ; N(R 10 )S(O) 2 R 10a ; N(R 10 )S(O)R 10a ; N(R 10 )C(O)N(R 10a R 10b ); N(R 10 )C(O)OR 10a ; OC(O)N(R 10 R 10a ); T 2 ; C 1-12 alkyl; C 2-12 alkenyl; or C 2-12 alkynyl, wherein C 1-12 alkyl; C 2-12 alkenyl; and C 2-12 alkynyl are optionally substituted with one or more R 11 , which are the same or different;

R 10 , R 10a , and R 10b are independently selected from the group consisting of H; T 2 ; C 1-12 alkyl; C 2-12 alkenyl; and C 2-12 alkynyl, wherein C 1-12 alkyl; C 2-12 alkenyl; and C 2-12 alkynyl are optionally substituted with one or more R 11 , which are the same or different;

T 2 is phenyl; C 3-7 cycloalkyl; 3 to 7 membered heterocyclyl; or 7 to 11 membered heterobicyclyl, wherein T 2 is optionally substituted with one or more R 12 , which are the same or different;

R 12 is halogen; CN; C(O)OR 13 ; OR 13 ; C(O)R 13 ; C(O)N(R 13 R 13a ); S(O) 2 N(R 13 R 13a ); S(O)N(R 13 R 13a ); S(O) 2 R 13 ; S(O)R 13 ; N(R 13 )S(O) 2 N(R 13a R 13b ); SR 13 ; N(R 13 R 13a ); OC(O)R 13 ; N(R 13 )C(O)R 13a ; N(R 13 )S(O) 2 R 13a ; N(R 13 )S(O)R 13a ; N(R 13 )C(O)OR 13a ; N(R 13 )C(O)N(R 13a R 13b ); OC(O)N(R 13 R 13a ); oxo (═O), where the ring is at least partially saturated; T 3 ; C 1-6 alkyl; C 2-6 alkenyl; or C 2-6 alkynyl, wherein C 1-6 alkyl; C 2-6 alkenyl; and C 2-6 alkynyl are optionally substituted with one or more R 14 , which are the same or different;

R 13 , R 13a , and R 13b are independently selected from the group consisting of H; C 1-6 alkyl; C 2-6 alkenyl; and C 2-6 alkynyl, wherein C 1-6 alkyl; C 2-6 alkenyl; and C 2-6 alkynyl are optionally substituted with one or more R 14 , which are the same or different;

R 11 and R 14 are independently selected from the group consisting of halogen; CN; C(O)OR 15 ; OR 15 ; C(O)R 15 ; C(O)N(R 15 R 15a ); S(O) 2 N(R 15 R 15a ); S(O)N(R 15 R 15a ); S(O) 2 R 15 ; S(O)R 15 ; N(R 15 )S(O) 2 N(R 15a R 15b ); SR 15 ; N(R 15 R 15a ); OC(O)R 15 ; N(R 15 )C(O)R 15a ; N(R 15 )S(O) 2 R 15a ; N(R 15 )S(O)R 15a ; N(R 15 )C(O)OR 15a ; N(R 15 )C(O)N(R 15a R 15b ); OC(O)N(R 15 R 15a ); and T 3 ;

R 15 , R 15a , and R 15b are independently selected from the group consisting of H; T 3 ; C 1-6 alkyl; C 2-6 alkenyl; and C 2-6 alkynyl, wherein C 1-6 alkyl; C 2-6 alkenyl; and C 2-6 alkynyl are optionally substituted with one or more halogen, which are the same or different;

T 3 is phenyl; C 3-7 cycloalkyl; or 3 to 7 membered heterocyclyl, wherein T 3 is optionally substituted with one or more R 16 , which are the same or different;

R 16 is halogen; CN; C(O)OR 17 ; OR 17 ; C(O)R 17 ; C(O)N(R 17 R 17a ); S(O) 2 N(R 17 R 17a ); S(O)N(R 17 R 17a ); S(O) 2 R 17 ; S(O)R 17 ; N(R 17 )S(O) 2 N(R 17a R 17b ); SR 17 ; N(R 17 R 17a ); OC(O)R 17 ; N(R 17 )C(O)R 17a ; N(R 17 )S(O) 2 R 17a ; N(R 17 )S(O)R 17a ; N(R 17 )C(O)OR 17a ; N(R 17 )C(O)N(R 17a R 17b ); OC(O)N(R 17 R 17a ); oxo (═O), where the ring is at least partially saturated; C 1-6 alkyl; C 2-6 alkenyl; or C 2-6 alkynyl, wherein C 1-6 alkyl; C 2-6 alkenyl; and C 2-6 alkynyl are optionally substituted with one or more halogen, which are the same or different;

R 17 , R 17a , and R 17b are independently selected from the group consisting of H; C 1-6 alkyl; C 2-6 alkenyl; and C 2-6 alkynyl, wherein C 1-6 alkyl; C 2-6 alkenyl; and C 2-6 alkynyl are optionally substituted with one or more halogen, which are the same or different;

R 4 is H; F; Cl; or N(CH 3 ) 2 ;

R 18 is H; C 1-6 alkyl; C 2-6 alkenyl; or C 2-6 alkynyl; wherein C 1-6 alkyl, C 2-6 alkenyl; and C 2-6 alkynyl are optionally substituted with one or more R 19 , which are the same or different;

R 19 is halogen; CN; C(O)OR 20 ; OR 20 ; C(O)R 20 ; C(O)N(R 20 R 20a ); S(O) 2 N(R 20 R 20a ); S(O)N(R 20 R 20a ); S(O) 2 R 20 ; S(O)R 20 ; N(R 20 )S(O) 2 N(R 20a R 20b ); SR 20 ; N(R 20 R 20a ); NO 2 ; OC(O)R 20 ; N(R 20 )C(O)R 20a ; N(R 20 )SO 2 R 20a ; N(R 20 )S(O)R 20a ; N(R 20 )C(O)N(R 20a R 20b ); N(R 20 )C(O)OR 20a ; or OC(O)N(R 20 R 20a ); and

R 20 , R 20a , and R 20b are independently selected from the group consisting of H; and C 1-6 alkyl, wherein C 1-6 alkyl is optionally substituted with one or more halogen, which are the same or different.

2. The pharmaceutical composition of claim 1 having formula (IIa)

3. The pharmaceutical composition of claim 1 , wherein R 18 is H.

4. The pharmaceutical composition of claim 1 , wherein X 1 is S(O) 2 .

5. The pharmaceutical composition of claim 1 , wherein R 1 is H.

6. The pharmaceutical composition of claim 1 , wherein X 2 is C(R 4 ).

7. The pharmaceutical composition of claim 1 , wherein R 4 is H; F; or N(CH 3 ) 2 .

8. The pharmaceutical composition of claim 1 , wherein R 2 is phenyl, 5 to 6 membered aromatic heterocyclyl, or 9 to 11 membered aromatic heterobicyclyl; and wherein R 2 is optionally substituted with one or two R 5 , which are the same or different.

9. The pharmaceutical composition of claim 1 , wherein R 2 is substituted with one or two R 5 , which are the same or different.

10. The pharmaceutical composition of claim 1 , wherein R 5 is halogen; CN; OR 6 ; C(O)N(R 6 R 6a ); T 1 ; or C 1-6 alkyl, wherein C 1-6 alkyl is optionally substituted with one or more halogen, which are the same or different.

11. The pharmaceutical composition of claim 1 , wherein T 1 is cyclopropyl; or 3 to 7 membered heterocyclyl, wherein T 1 is unsubstituted or substituted with unsubstituted C 1-6 alkyl.

12. The pharmaceutical composition of claim 1 , wherein R 2 in formula (I) is selected to give formula (IIaa) or (IIab)

13. The pharmaceutical composition of claim 1 , wherein R 3a is T 2 ; C 1-12 alkyl; unsubstituted C 2-12 alkenyl; or unsubstituted C 2-12 alkynyl, wherein C 1-12 alkyl is optionally substituted with one, two or three R 9 , which are the same or different.

14. The pharmaceutical composition of claim 1 , wherein T 2 is phenyl; C 3-7 cycloalkyl; or 3 to 7 membered heterocyclyl, wherein T 2 is optionally substituted with one or more R 12 , which are the same or different.

15. The pharmaceutical composition of claim 1 , wherein T 2 is unsubstituted or substituted with one or two R 12 , which are the same or different.

16. The pharmaceutical composition of claim 1 , wherein R 12 is halogen; OR 13 ; unsubstituted T 3 ; T 3 which is substituted with unsubstituted C 1-6 alkyl; or unsubstituted C 1-6 alkyl.

17. The pharmaceutical composition of claim 1 , wherein in formula (I) X 1 , X 2 , R 1 , R 2 , R 3 , and R 18 are selected to give:

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(2,2-difluorocyclopropyl)-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-butyl-5-[(4-tert-butylphenyl)methyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-butyl-4-oxo-5-{[4-(trifluoromethoxy)phenyl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-tert-butylphenyl)methyl]-4-oxo-N-(propan-2-yl)-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-butyl-8-fluoro-4-oxo-5-{[4-(trifluoromethoxy)phenyl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-benzyl-4-oxo-5-{[4-(trifluoromethoxy)phenyl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-[(4-methoxyphenyl)methyl]-4-oxo-5-{[4-(trifluoromethoxy)-phenyl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-(oxan-4-yl)-4-oxo-5-{[4-(trifluoromethoxy)phenyl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-butyl-4-oxo-5-{[3-(trifluoromethoxy)phenyl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-butyl-5-[(4-chlorophenyl)methyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-{[4-(morpholin-4-yl)phenyl]methyl}-4-oxo-5-{[4-(trifluoromethoxy)-phenyl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

N-(3-{[(3R)-3-amino-4-oxo-5-{[4-(trifluoromethoxy)phenyl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepin-7-yl]formamido}propyl)-2,2-dimethylpropanamide;

(3R)-3-amino-N-butyl-5-{[4-(morpholin-4-yl)phenyl]methyl}-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-8-fluoro-N-(oxan-4-yl)-4-oxo-5-{[4-(trifluoromethoxy)phenyl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-8-fluoro-4-oxo-N-(propan-2-yl)-5-{[4-(trifluoromethoxy)phenyl]-methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-benzyl-8-fluoro-4-oxo-5-{[4-(trifluoromethoxy)phenyl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-methyl-4-oxo-5-{[4-(trifluoromethoxy)phenyl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-ethyl-4-oxo-5-{[4-(trifluoromethoxy)phenyl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-({4-[(5-acetamidopentyl)oxy]phenyl}methyl)-4-oxo-5-{[4-(trifluoromethoxy)phenyl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(2-methoxyethyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-butyl-5-[(4-cyanophenyl)methyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-4-oxo-N-(4,4,4-trifluorobutyl)-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(oxan-4-ylmethyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-(5-tert-butyl-1,2-oxazol-3-yl)-5-[(4-chlorophenyl)methyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-4-oxo-N-(pyridin-3-yl)-5-{[4-(trifluoromethoxy)phenyl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(4-fluorophenyl)methyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(1R)-1-(4-methoxyphenyl)ethyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(oxan-3-ylmethyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-4-oxo-N-(4,4,4-trifluorobutyl)-5-{[4-(trifluoromethoxy)phenyl]methyl}2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-(oxan-4-ylmethyl)-4-oxo-5-{[4-(trifluoromethoxy)phenyl]-methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-[(4-fluorophenyl)methyl]-4-oxo-5-{[4-(trifluoromethoxy)phenyl]-methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-[(4-fluorophenyl)methyl]-4-oxo-5-{[4-(1,2,3-thiadiazol-4-yl)phenyl]-methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(4,4-difluorocyclohexyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[1-(4-fluorophenyl)ethyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(1S)-1-(4-methoxyphenyl)ethyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-4-oxo-N-(4,4,4-trifluorobutyl)-5-{[6-(trifluoromethyl)pyridin-3-yl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-[(4-fluorophenyl)methyl]-4-oxo-5-{[6-(trifluoromethyl)pyridin-3-yl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(1R)-1-(4-fluorophenyl)ethyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(4-fluorophenyl)methyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-4-oxo-N-(4,4,4-trifluorobutyl)-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-butyl-5-[(4-chlorophenyl)methyl]-8-fluoro-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-(oxan-4-yl methyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(4-methoxyphenyl)methyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-{[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl}-N-(oxan-4-ylmethyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-fluorophenyl)methyl]-N-(oxan-4-ylmethyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-butyl-4-oxo-5-{[4-(1H-1,2,4-triazol-1-yl)phenyl]methyl}-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-butyl-5-[(4-carbamoyl phenyl)methyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(2-hydroxy-2-methylpropyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(1S)-1-(4-fluorophenyl)ethyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-(2-hydroxy-2-methylpropyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-4-oxo-N-(4,4,4-trifluorobutyl)-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N′-(4-fluorophenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carbohydrazide;

(3R)-3-amino-N-butanoyl-5-[(4-chlorophenyl)methyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carbohydrazide;

(3R)-3-amino-N-butyl-5-[(4-chloro-2-fluorophenyl)methyl]-8-fluoro-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chloro-2-fluorophenyl)methyl]-8-fluoro-N-(oxan-4-ylmethyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chloro-3-fluorophenyl)methyl]-8-fluoro-N-(oxan-4-ylmethyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-butyl-5-[(4-chloro-3-fluorophenyl)methyl]-8-fluoro-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-4-oxo-N-propoxy-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-(2-methyl propoxy)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N′-(2-methyl propyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carbohydrazide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-4-oxo-N-(propan-2-yl)-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(2-methylpropoxy)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(3-methyl butan-2-yl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-(but-3-en-1-yl)-5-[(4-chlorophenyl)methyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N′-(2-methylpropyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carbohydrazide;

(3R)-3-amino-N-butyl-5-[(4-chlorophenyl)methyl]-1,4-dioxo-2,3,4,5-tetrahydro-1λ 4 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-butyl-1,1,4-trioxo-5-{[4-(trifluoromethoxy)phenyl]methyl}-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(4-fluorophenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-butyl-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-N-(4,4,4-trifluoro-butyl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-(oxan-4-ylmethyl)-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-8-fluoro-N-(oxan-4-yl methyl)-1,1,4-trioxo-5-{[4-(trifluoromethoxy)-phenyl]methyl}-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-8-fluoro-1,1,4-trioxo-N-(4,4,4-trifluorobutyl)-5-{[4-(trifluoromethoxy)-phenyl]methyl}-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-8-fluoro-1,1,4-trioxo-N-phenoxy-5-{[4-(trifluoromethoxy)phenyl]methyl}-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-(2-methylpropoxy)-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-N-phenoxy-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-N-(propan-2-yl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-({4-[(5-acetamidopentyl)oxy]phenyl}-methyl)-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-1,1,4-trioxo-N-(propan-2-yl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-1,1,4-trioxo-N-(4,4,4-trifluorobutyl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(2-methylpropoxy)-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-1,1,4-trioxo-N-propoxy-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(3-methylbutan-2-yl)-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-(but-3-en-1-yl)-5-[(4-chlorophenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-cyclopropyl-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-cyclobutyl-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chloro-2-fluorophenyl)methyl]-8-fluoro-1,1,4-trioxo-N-(propan-2-yl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(3,4-dichlorophenyl)methyl]-1,1,4-trioxo-N-(propan-2-yl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chloro-3-fluorophenyl)methyl]-1,1,4-trioxo-N-(propan-2-yl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(cyclohexyloxy)-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(cyclohexylmethoxy)-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-N-(2,2,2-trifluoro-ethyl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-N-(3,3,3-trifluoro-propyl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-N-[(2S)-1,1,1-trifluoropropan-2-yl]-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-(butan-2-yl)-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-tert-butyl-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-(tert-butoxy)-5-[(4-chlorophenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-N-[(1S,2R)-2-phenylcyclopropyl]-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-(1-methylcyclopropyl)-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-(1-methylcyclobutyl)-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(2,2-dimethylcyclopropyl)-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(3,3-difluorocyclobutyl)-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-benzyl-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-heptyl-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(3,3-difluorocyclopentyl)-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(1R)-2,2-difluorocyclopropyl]-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(1S)-2,2-difluorocyclopropyl]-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(2R,3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(2,2-difluorocyclopropyl)-2-methyl-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-hexadecyl-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(cyclopropylmethyl)-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(2R,3R)-3-amino-5-[(4-chlorophenyl)methyl]-2-methyl-1,1,4-trioxo-N-(4,4,4-trifluorobutyl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-butyl-8-fluoro-4-oxo-5-(quinolin-2-ylmethyl)-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(5-cyclopropyl-1,3,4-thiadiazol-2-yl)methyl]-8-fluoro-N-[(4-fluorophenyl)methyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-butyl-5-[(4-chlorophenyl)methyl]-8-(dimethylamino)-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

tert-butyl N-(5-{[(3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-7-{[(4-methoxyphenyl)methyl]carbamoyl}-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl]amino}pentyl)carbamate;

(3R)-3-amino-N-butyl-1-[(4-chlorophenyl)methyl]-2,5,5-trioxo-1H,2H,3H,4H-5λ 6 -pyrido[3,4-b][1,4]thiazepine-8-carboxamide;

(3R)-3-amino-N-benzyl-5-[(4-chlorophenyl)methyl]-8-(dimethylamino)-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 , 5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-(2,2-difluorocyclopropyl)-8-fluoro-5-{[4-methoxy-3-(trifluoromethyl)phenyl]methyl}-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(2R,3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-2-methyl-1,1,4-trioxo-N-(4,4,4-trifluorobutyl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-{[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl}-1,1,4-trioxo-N-(4,4,4-trifluorobutyl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-(2-methoxyethyl)-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-(2,2-difluorocyclopropyl)-5-{[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl}-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(1S,3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-4-oxo-7-[(4,4,4-trifluorobutyl)carbamoyl]-2,3,4,5-tetrahydro-1H-1,5-benzothiazepin-1-ium-1-olate;

(1R,3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-4-oxo-7-[(4,4,4-trifluorobutyl)carbamoyl]-2,3,4,5-tetrahydro-1H-1,5-benzothiazepin-1-ium-1-olate;

(3R)-3-amino-5-[(4-cyanophenyl)methyl]-N-(2,2-difluorocyclopropyl)-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-cyanophenyl)methyl]-8-fluoro-1,1,4-trioxo-N-(4,4,4-trifluorobutyl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(4,4-difluorocyclohexyl-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-N-[2-(trifluoromethyl)cyclopropyl]-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(3,3-difluorocyclobutyl)-8-fluoro-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-8-fluoro-5-[(4-fluorophenyl)methyl]-1,1,4-trioxo-N-(4,4,4-trifluorobutyl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-(2,2-difluorocyclopropyl)-8-fluoro-5-[(4-fluorophenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-butyl-8-fluoro-5-[(4-fluorophenyl)methyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-benzyl-8-fluoro-5-[(4-fluorophenyl)methyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-butyl-8-fluoro-5-[(4-fluorophenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-benzyl-8-fluoro-5-[(4-fluorophenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[2-(oxan-4-yl)ethyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-benzyl-8-fluoro-1,1,4-trioxo-N-(4,4,4-trifluorobutyl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(4-methoxyphenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(5-cyclopropyl-1,3,4-thiadiazol-2-yl)methyl]-8-fluoro-N-[(4-fluorophenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-8-fluoro-5-[(4-fluorophenyl)methyl]-N-[(oxan-4-yl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-(3,3-difluorocyclobutyl-8-fluoro-5-[(4-fluorophenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-8-fluoro-5-[(4-methoxyphenyl)methyl]-1,1,4-trioxo-N-(4,4,4-trifluorobutyl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-8-fluoro-5-[(4-methoxyphenyl)methyl]-N-[(oxan-4-yl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-(2,2-difluorocyclopropyl)-8-fluoro-5-[(4-methoxyphenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-(oxan-4-yl)-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-(3,3-difluorocyclobutyl)-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(1S)-3,3-difluorocyclopentyl]-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(1R,2S)-2-fluorocyclopropyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-(3,3-difluorocyclobutyl)-5-[(2-fluorophenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-(3,3-difluorocyclobutyl)-5-[(3-methoxyphenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-methoxyphenyl)methyl]-1,1,4-trioxo-N-(4,4,4-trifluorobutyl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N,5-bis[(4-methoxyphenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-benzyl-N-[(4-methoxyphenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(4-methoxyphenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-(4,4-difluorocyclohexyl)-5-[(4-methoxyphenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 , 5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-1,1,4-trioxo-N-(3,3,3-trifluoropropyl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-1,1,4-trioxo-N-[(3R)-oxolan-3-yl]-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-1,1,4-trioxo-N-[(oxolan-3-yl)methyl]-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(1R)-2,2-difluorocyclopropyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-cyclopropylphenyl)methyl]-N-[(1R)-2,2-difluorocyclopropyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-[(1R)-2,2-difluorocyclopropyl]-5-{[4-(difluoromethoxy)phenyl]methyl}-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-[(1R)-2,2-difluorocyclopropyl]-5-[(4-methoxyphenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-benzyl-1,1,4-trioxo-N-(4,4,4-trifluorobutyl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-8-chloro-5-[(4-chlorophenyl)methyl]-1,1,4-trioxo-N-(4,4,4-trifluorobutyl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-{[4-(difluoromethoxy)phenyl]methyl}-N-[(oxan-4-yl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(4-fluorooxan-4-yl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(1R)-1-(oxan-4-yl)ethyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-benzyl-N-[(1R)-2,2-difluorocyclopropyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(6-methylpyridin-3-yl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(1R)-3,3-difluorocyclopentyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-cyanophenyl)methyl]-8-fluoro-N-[(4-fluorophenyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(3,3-difluorocyclobutyl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[2-(2-methoxyethoxy)ethyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-(but-3-yn-1-yl)-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-N-(pent-4-yn-1-yl)-2,3,4,5-tetrahydro-1λ 6 , 5-benzothiazepine-7-carboxamide;

(3R)-3-amino-8-chloro-5-[(4-chlorophenyl)methyl]-N-[(1R)-2,2-difluorocyclopropyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[2-(morpholin-4-yl)ethyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-[(6-methoxypyridin-3-yl)methyl]-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-N-{[4-(prop-2-yn-1-yloxy)phenyl]methyl}-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-N-[(1R)-2,2-difluorocyclopropyl]-1,1,4-trioxo-5-{[4-(trifluoromethyl)phenyl]methyl}-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-bromophenyl)methyl]-N-(2,2-difluorocyclopropyl)-1,1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide;

(3R)-3-amino-5-[(4-chlorophenyl)methyl]-N-{2-oxaspiro[3.3]heptan-6-yl}-, 1,4-trioxo-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide; or

(3R)-5-[(4-chlorophenyl)methyl]-3-(ethylamino)-8-fluoro-1,1,4-trioxo-N-(4,4,4-trifluorobutyl)-2,3,4,5-tetrahydro-1λ 6 ,5-benzothiazepine-7-carboxamide.

18. A compound or a pharmaceutically acceptable salt thereof as defined claim 1 .

19. The compound or pharmaceutically acceptable salt thereof of claim 18 , wherein the following compound or a pharmaceutically acceptable salt thereof is excluded:

20. The compound or pharmaceutically acceptable salt thereof claim 18 , wherein the following compounds or pharmaceutically acceptable salts thereof are excluded:

wherein X 1 is S; S(O); or S(O) 2 ;

R 2 is phenyl; 3-chlorophenyl; 4-fluorophenyl; 4-methoxyphenyl; 3,5-dimethyl-1,2-oxazol-4-yl; 2-chlorothiophen-5-yl; pyridin-4-yl; 1,3-benzodioxol-5-yl; 5-phenyl-1,2,4-oxadiazol-3-yl; 3-(4-tert butylphenyl)-1,2,4-oxadiazol-5-yl; biphen-4-yl; or 3,4,5-trimethoxyphenyl; and

R 3 is n-butyl; 2-hydroxy-1-hydroxycarbonyl-ethyl; 2-hydroxycarbonylethyl; phenyl; or benzyl.

21. The compound or pharmaceutically acceptable salt thereof of claim 18 , wherein the following compounds or pharmaceutically acceptable salts thereof are excluded:

wherein X 1 is S; S(O); or S(O) 2 ;

R 2 is phenyl; 3 to 7 membered heterocyclyl; or 7 to 11 membered heterobicyclyl, wherein R 2 is optionally substituted with one or more R 5 , which are the same or different; and

R 3 is n-butyl; 2-hydroxy-1-hydroxycarbonyl-ethyl; 2-hydroxycarbonylethyl; phenyl; or benzyl.

22. The pharmaceutical composition of claim 7 , wherein R 4 is H or F.

23. The pharmaceutical composition of claim 8 , wherein R 2 is phenyl, pyridyl, thiadiazolyl, or quinolinyl; and wherein R 2 is optionally substituted with one or two R 5 , which are the same or different.

24. The pharmaceutical composition of claim 8 , wherein R 2 is phenyl or pyridyl; and wherein R 2 is optionally substituted with one or two R 5 , which are the same or different.

25. The pharmaceutical composition of claim 8 , wherein R 2 is phenyl; and wherein R 2 is optionally substituted with one or two R 5 , which are the same or different.

26. The pharmaceutical composition of claim 10 , wherein R 5 is F; Cl; Br; CN; OCH 3 ; OCHF 2 ; OCF 3 ; C(O)NH 2 ; 1H-1,2,4-triazol-1yl; cyclopropyl; 5-methyl-1,2,4-oxadiazol-3-yl; 1,2,3thiadiazol-4yl; morpholin-4-yl; tert-butyl; or CF 3 .

27. The pharmaceutical composition of claim 10 , wherein R 5 is F; Cl; CN; OCF 3 ; C(O)NH 2 ; 1H-1,2,4-triazol-1-yl; cyclopropyl; 5-methyl-1,2,4-oxadiazol-3-yl; 1,2,3-thiadiazol-4-yl; morpholin-4-yl; tert-butyl; or CF 3 .

28. The pharmaceutical composition of claim 13 , wherein R 3a is T 2 ; C 1-12 alkyl; or C 2-12 alkenyl, wherein C 1-12 alkyl is optionally substituted with one, two or three R 9 , which are the same or different.

29. The pharmaceutical composition of claim 13 , wherein R 3a is T 2 ; CH 2 T 2 ; CH 2 CH 2 T 2 ; C(CH 3 )T 2 ; unsubstituted C 1-12 alkyl; unsubstituted C 2-12 alkenyl; C 1-12 alkyl which is substituted with OR 10 ; N(R 10 )C(O)R 10a ; C 1-12 alkyl; or CF 3 .

30. An in vitro or ex vivo method for the production of activated immune cells comprising the steps of:

(i) providing immune cells;

(ii) contacting the cells of step (i) with:

(a) at least one compound or pharmaceutically acceptable salt thereof as defined in claim 1 , and optionally

(b) one or more further stimulating agents activating said immune cells; and

(iii) cultivating the cells of step (ii) under conditions suitable for maintaining the viability of said cells.

Assignments (9)
CHANGE OF NAME Recorded Jan 3, 2025
From: APEIRON BIOLOGICS AG
To: APEIRON BIOLOGICS GMBH
Reel/Frame 069848/0326 →
SECURITY INTEREST Recorded Dec 23, 2024
From: APEIRON BIOLOGICS GMBH
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 069669/0908 →
CHANGE OF NAME Recorded Aug 5, 2019
From: EVOTEC AG
To: EVOTEC SE
Reel/Frame 049962/0929 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2018
From: HANKE, THOMAS; WEHR, ROLAND
To: EVOTEC INTERNATIONAL GMBH
Reel/Frame 046098/0472 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2018
From: EVOTEC INTERNATIONAL GMBH
To: EVOTEC AG
Reel/Frame 046098/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2018
From: STERNBERGER, INA
To: EVOTEC AG
Reel/Frame 046098/0493 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2018
From: LAMETSCHWANDTNER, GUENTHER; LOIBNER, HANS; STUETZ, ANTON
To: APEIRON BIOLOGICS AG
Reel/Frame 046098/0519 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2018
From: EVOTEC (UK) LIMITED
To: EVOTEC AG
Reel/Frame 046098/0449 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2018
From: ERMANN, MONIKA; AMOUZEGH, PATRICIA LEONIE; CRAFT, RUSSEL STUART; JAMES, TIMOTHY ROBIN; JONES, SEVERINE DANIELLE; LOKE, PUI LENG; WHITTAKER, MARK
To: EVOTEC (UK) LIMITED
Reel/Frame 046098/0401 →
Priority Claims (1)
EP 15157175 · Mar 2, 2015 · regional
Continuity (1)
Related Publication 20180170888A1 · Jun 21, 2018